From: Clinical relevance of SARS-CoV-2 infection in late pregnancy
Characteristics | Sars-Cov-2 infection | Controls | p |
---|---|---|---|
n = 28 | n = 287 | ||
Gestational Diabetes Mellitus | 3 (10.7%) | 22 (7.7%) | 0.48 |
Hypertensive disorders | 2 (7.1%) | 6 (2.1%) | 0.15 |
Intrahepatic cholestasis | 1 (3.6%) | 5 (1.7%) | 0.43 |
Preterm delivery (< 37 weeks' gestation) | 2 (7.1%) | 22 (7.7%) | 1.00 |
Cesarean section | 10 (35.7%) | 108 (37.6%) | 1.00 |
SGA newborns a | 2 (7.4%) | 30 (10.8%) | 0.75 |
LGA newborns a | 1 (3.7%) | 23 (8.3%) | 0.71 |
Stilbirth | 0 (0.0%) | 0 (0.0%) | n.a |
Early neonatal death | 0 (0.0%) | 0 (0.0%) | n.a |
Maternal death | 0 (0.0%) | 0 (0.0%) | n.a |
Apgar score at 1 min < 7 | 2 (7.1%) | 8 (2.8%) | 0.22 |
Neonatal pH < 7.10 | 2 (7.1%) | 11 (3.8%) | 0.32 |
NICU admission | 5 (18%) | 21 (7%) | 0.07 |